The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.38
Bid: 56.52
Ask: 56.56
Change: 0.20 (0.36%)
Spread: 0.04 (0.071%)
Open: 55.94
High: 57.22
Low: 55.94
Prev. Close: 56.38
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Dec 2020 07:00

RNS Number : 0199H
Lloyds Banking Group PLC
01 December 2020
 

 

 

1 December 2020

 

 

Director Change - Lloyds Banking Group plc

Following the announcement yesterday that the Group has completed its succession planning with the appointment of Charlie Nunn to join the Group as the new Group Chief Executive Officer in 2021, António Horta-Osório has informed the Board that he has agreed to be proposed for election as Chairman of the Board of Credit Suisse Group AG with effect from 1st May 2021. Accordingly, he has agreed with the Board that he will step down as Group CEO and as a Director of the Group with effect from 30th April 2021. He will continue to fulfil all his current responsibilities until that date.

Lord Blackwell, Chairman, commented "On behalf of the Board I would like to congratulate António on this new role as he moves on after 10 years as Group Chief Executive Officer of Lloyds Banking Group. During his tenure he has transformed the Group's fortunes and established a solid operational and strategic base from which it can continue to build a successful future. He will leave next year with the Board's gratitude for all he has achieved, and for his assistance and support in our planning for the leadership succession."

As noted in yesterday's announcement, the Board has agreed that in the event of an interim period between Mr Horta-Osório stepping down and Mr Nunn joining the Group, William Chalmers, Group Chief Financial Officer will subject to regulatory approval take on the role of acting Group CEO in addition to his ongoing responsibilities as Group CFO, with the support of Robin Budenberg and Alan Dickinson in their roles as Chairman and Deputy Chairman. Arrangements would be made to support him in this role and manage his wider responsibilities appropriately.

 

- ENDS -

For further information

 

Investor Relations

Douglas Radcliffe +44 (0) 20 7356 1571

Group Investor Relations Director

douglas.radcliffe@lloydsbanking.com 

 

Corporate Affairs

Matt Smith +44 (0) 20 7356 3522

Head of Media Relations

matt.smith@lloydsbanking.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPGGAGUPUPGU
Date   Source Headline
22nd Feb 20247:00 amRNS2023 Annual Report and Accounts
20th Feb 20242:05 pmRNSReplacement Block listing Interim Review
20th Feb 20242:00 pmRNSReplacement Block listing Interim Review
15th Feb 20247:00 amRNSBoard Change
31st Jan 20243:56 pmRNSTotal Voting Rights
25th Jan 20245:07 pmRNSBoard Committee Change
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
5th Jan 20241:50 pmRNSPublication of Final Terms
2nd Jan 202412:00 pmRNSBlock listing Interim Review
29th Dec 202310:30 amRNSTotal Voting Rights
18th Dec 20232:30 pmRNSBoard Committee Change
18th Dec 20232:00 pmRNSDirector/PDMR Shareholding
12th Dec 20234:00 pmRNSDirector/PDMR Shareholding
30th Nov 20232:00 pmRNSTotal Voting Rights
20th Nov 20232:00 pmRNSBlock Listing of Shares
10th Nov 20234:00 pmRNSDirector/PDMR Shareholding
6th Nov 20233:57 pmRNSPublication of Final Terms
31st Oct 202311:20 amRNSTotal Voting Rights
26th Oct 20233:47 pmRNSPublication of Suppl.Prospcts
26th Oct 20231:02 pmRNSPublication of Suppl.Prospcts
26th Oct 202312:59 pmRNSPublication of Suppl.Prospcts - Correction
25th Oct 202312:09 pmRNSPublication of Suppl.Prospcts
25th Oct 202311:57 amRNS2023 Q3 Interim Management Statement
25th Oct 20237:00 amRNS2023 Q3 Interim Management Statement
11th Oct 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
21st Sep 20231:28 pmRNSPublication of Final Terms
20th Sep 20232:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:00 pmRNSDirector/PDMR Shareholding
13th Sep 20232:00 pmRNSBoard and Committee changes
13th Sep 20231:45 pmRNSDirector/PDMR Shareholding
13th Sep 20239:20 amRNS2023 Half-Year Results
31st Aug 202312:00 pmRNSTotal Voting Rights
29th Aug 20237:21 amRNSCompletion of £2 billion Share Buyback Programme
25th Aug 20235:51 pmRNSTransaction in Own Shares
24th Aug 20235:38 pmRNSTransaction in Own Shares
24th Aug 20235:30 pmRNSTotal Voting Rights
23rd Aug 20235:21 pmRNSTransaction in Own Shares
22nd Aug 20235:18 pmRNSTransaction in Own Shares
22nd Aug 202311:44 amRNSPublication of Pricing Supplement
22nd Aug 20239:39 amRNSStabilisation Notice
21st Aug 20235:14 pmRNSTransaction in Own Shares
18th Aug 20235:37 pmRNSTransaction in Own Shares
17th Aug 20235:39 pmRNSTransaction in Own Shares
16th Aug 20235:29 pmRNSTransaction in Own Shares
15th Aug 20235:28 pmRNSTransaction in Own Shares
14th Aug 20235:36 pmRNSTransaction in Own Shares
11th Aug 20235:49 pmRNSTransaction in Own Shares
10th Aug 20235:42 pmRNSTransaction in Own Shares
10th Aug 20232:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.